17beta-estradiol promotes the odonto/osteogenic differentiation of stem cells from apical papilla via mitogen-activated protein kinase pathway
© Li et al.; licensee BioMed Central Ltd. 2014
Received: 13 February 2014
Accepted: 29 October 2014
Published: 17 November 2014
Estrogen plays an important role in the osteogenic differentiation of mesenchymal stem cells, while stem cells from apical papilla (SCAP) can contribute to the formation of dentin/bone-like tissues. To date, the effects of estrogen on the differentiation of SCAP remain unclear.
SCAP was isolated and treated with 10-7 M 17beta-estradiol (E2). The odonto/osteogenic potency and the involvement of mitogen-activated protein kinase (MAPK) signaling pathway were subsequently investigated by using methyl-thiazolyl-tetrazolium (MTT) assay, and other methods.
MTT and flow cytometry results demonstrated that E2 treatment had no effect on the proliferation of SCAP in vitro, while alkaline phosphatase (ALP) assay and alizarin red staining showed that E2 can significantly promote ALP activity and mineralization ability in SCAP. Real-time reverse transcription polymerase chain reaction (RT-PCR) and western blot assay revealed that the odonto/osteogenic markers (ALP, DMP1/DMP1, DSPP/DSP, RUNX2/RUNX2, OSX/OSX and OCN/OCN) were significantly upregulated in E2-treated SCAP. In addition, the expression of phosphor-p38 and phosphor-JNK in these stem cells was enhanced by E2 treatment, as was the expression of the nuclear downstream transcription factors including phosphor-Sp1, phosphor-Elk-1, phosphor-c-Jun and phosphor-c-Fos, indicating the activation of MAPK signaling pathway during the odonto/osteogenic differentiation of E2-treated SCAP. Conversely, the differentiation of E2-treated SCAP was inhibited in the presence of MAPK specific inhibitors.
The ondonto/osteogenic differentiation of SCAP is enhanced by 10-7 M 17beta-estradiol via the activation of MAPK signaling pathway.
When the dental pulp of a young tooth with open apex is infected due to caries or trauma, dentists often try to take measures (for example, apexification and apexogenesis) to preserve the root development and maturation. During the process, a series of factors are involved in the growth of the root, for instance, stem cells from apical papilla (SCAP), which still exist after the formation of the root and can survive the infection[2, 3]. SCAP have a high proliferation rate and possess osteo/dentinogenic and adipogenic potentials[4, 5]. When transplanted into immunocompromised mice, SCAP can form a typical dentin-pulp-like complex and generate bone-like tissues containing osteoblast-like cells[4–6]. Moreover, the combination of SCAP and periodontal ligament stem cells (PDLSCs) can produce dentin and cementum with collagen fibers anchored into the cementum after transplantation in vivo, which represents an approach to biological root engineering. Thus, such a biological root supporting a porcelain crown can restore a missing tooth instead of bridges and removable dentures. Huang et al. have suggested that SCAP play an important role in root formation. Many factors can affect the proliferation and odonto/osteogenic differentiation of SCAP, including culture medium, cell phenotype, medicaments, growth factors, hormones, morphogens, and so on[8–11] that demonstrate the importance of the extrinsic microenvironment to SCAP when applied in tissue engineering.
Hormones are very important to the growth, development, reproduction and maintenance of a diverse range of mammalian tissues. Estrogen is known as one of the important hormones for sex maturation and bone metabolism. Previous research has revealed a close relationship between estrogen deficiency and osteoporosis that occurs in postmenopausal women, and older men as well, leading to decreased bone mineral density and even bone fracture. It has also been demonstrated that periodontal diseases are related to estrogen deficiency which causes impaired osteogenic differentiation of PDLSCs. Furthermore, an in vivo study has shown that the differentiation ability of dental pulp stem cells (DPSCs) was downregulated in estrogen deficient rats. Recent studies have suggested that exogenous estrogen can enhance the proliferation and differentiation of bone marrow mesenchymal stem cells (BMMSCs), PDLSCs and DPSCs[8, 15, 16]. To date, the effects of estrogen on SCAP remain unclear.
In this study, we investigated the influence of estrogen on the proliferation and odonto/osteogenic differentiation of SCAP in vitro. SCAP was isolated from extracted third molars and exposed to 17beta-estradiol (E2). Then, the proliferation, differentiation and involvement of the MAPK signaling pathway in E2-treated SCAP were determined. Our findings suggest that E2 can enhance the odonto/osteogenic differentiation of SCAP via the MAPK pathway.
Cell isolation and culture
Impacted non-carious third molars (n = 20) were collected from young patients (17- to 20-years old) in the Oral Surgery Department of Jiangsu Provincial Stomatological Hospital. This study was approved by the Ethical Committee of the Stomatological School of Nanjing Medical University (Reference #200900128), and consent from patients was obtained. The apical papillae were carefully separated from the immature roots, minced and digested in a solution containing 3 mg/ml collagenase type I (Sigma, St. Louis, MO, USA) and 4 mg/ml dispase (Sigma) for 30 minutes at 37°C. Single cell suspensions were obtained and cells from different patients were mixed. Isolated cells were cultured in alpha minimum essential medium (α-MEM, Gibco, Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS, Hyclone, Logan, UT, USA), 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2. 17beta-estradiol (E2, Ehrenstorfer Gmbh, Augsburg, Germany) was dissolved in absolute ethyl alcohol at 10-3 M and stored at -20°C in the dark. In the subsequent experiments, cells were cultured in α-MEM containing E2 (E2 group) or 0.01% (v/v) ethyl alcohol as control (control group). The culture medium was changed every two days. JNK and p38 specific inhibitors SP600125 (Sigma-Aldrich, St. Louis, MO, USA) and SB203580 (Sigma-Aldrich) were dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich) at 100 mM and 20 mM, respectively and stored at -20°C in the dark. They were diluted to 20 μM when added to the culture media. Cells at passages two to four were used for the following experiments.
To determine the origin of the obtained mesenchymal stem cells, isolated cells were immunostained with antibody against STRO-1 (1:200, Novus Biologicals, Littleton, CO, USA) and their surface markers were measured by flow cytometry. Cells were harvested and incubated with fluorochrome-conjugated rabbit anti-human antibodies: CD34-FITC, CD45-PerCP, CD90-PE, CD105-APC, CD146-APC, CD73-PE (Miltenyi, Bergisch Gladbach, Germany) for 20 minutes at room temperature in the dark. Stained cells were washed twice with 0.01 M phosphate buffer solution (PBS) and analyzed by BD FACSCalibur (BD Biosciences, San Jose, CA, USA).
In vivo transplantation
The animal experiments were approved by the Ethical Committee of the Stomatological School of Nanjing Medical University. SCAP (1 × 106) was collected as a pellet in a sterile tube and seeded gently onto absorbable gelatin sponges (AGS, Nanjing Pharmaceuticals, Nanjing, China), which served as carriers. Then, cell pellets were transplanted into the renal capsules of immunodeficient female rats. After in vivo culture for eight weeks, the retrieved implants (n = 6) were fixed in 4% polyoxymethylene, decalcified and processed for hematoxylin and eosin (H & E) staining.
Immunohistochemistry and immunocytochemistry
Immunohistochemical and immunocytochemical analyses of human tissues or human SCAP were performed by the streptavidin-biotin complex method using the primary antibodies (STRO-1, 1:200, Santa Cruz, Dallas, TX, USA; ER-α, 1:100, Abcam, Cambridge, UK) according to the manufacturers’ recommended protocols[18, 19]. The reaction products were developed in 3, 3′-diaminobenzidine solution with hydrogen peroxide and counterstained with hematoxylin.
SCAP were seeded into 96-well plates (Nunc, Thermo Scientific, Waltham, MA, USA) at a density of 2 × 103 cells/well for 24 hours and starved in a serum-free medium for another 24 hours. Then the medium was changed to complete medium containing E2. At different time points (days 0, 1, 3, 5, 7, 9 and 11), the cells were treated with MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl-2, 5-tetrazoliumbromide) solution (5 mg/ml; Sigma-Aldrich) and incubated at 37°C for four hours. Then, the solution was removed and 150 μl/well DMSO was added. The absorbance (OD value) was measured at 490 nm with an automatic enzyme-linked immunosorbent assay reader (ELx800, BioTek Instruments Inc., Grand Island, NY, USA). The experiment was repeated three times and MTT results are expressed as the mean ± SD.
Colony forming assay
SCAP in the control group and the E2 group were seeded into six-well plates (Nunc, USA) at a density of 1 × 102 cells/well for two weeks. Then, the cells were fixed with 4% paraformaldehyde (PFA), stained with crystal violet (Beyotime, Shanghai, China) and photographed. The colonies were visualized under an inverted microscope (Olympus, Hamburg, Germany). Aggregations of more than 50 cells were defined as colonies and then counted. The experiment was repeated three times.
Flow cytometry for cell cycle
SCAP were plated into 6-cm culture dishes (Nunc, USA), cultured in α-MEM supplemented with 10% FBS until 60% to 70% confluence, and then serum-starved for 24 hours. E2 was added to the culture media of the experimental groups. After three days of incubation, the cells were harvested and fixed with 75% ice-cold ethanol at 4°C for 30 minutes in the dark. DNA content was measured by FAC-Scan flow cytometer (BD Biosciences, San Jose, CA, USA). Cell cycle fractions (G0/G1, S, and G2/M phases) were determined by flow cytometry (FCM). The experiment was repeated three times.
Alkaline phosphatase (ALP) activity assay and alizarin red staining
SCAP in the control group and the E2 group were seeded into 96-well plates (Nunc, USA) at a density of 2 × 103 cells/well or 24-well plates (Nunc, USA) at a density of 1 × 104 cells/well and cultured in routine media or mineralization-inducing media (MM) containing α-MEM, 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μM ascorbic acid, 2 mM 2-glycerophosphate and 10 nM dexamethasone. Alkaline phosphatase (ALP) activity assay was performed as previously reported by using an ALP activity kit (Sigma-Aldrich) and normalized to total protein content in the cells at days 5 and 7. At day 14, alizarin red staining was carried out as described before and images were acquired using a scanner. Then, nodule staining was destained by 10% cetylpyridinium chloride (CPC) in 10 mM sodium phosphate for 30 minutes at room temperature. The calcium concentration was determined by measuring the absorbance at 526 nm with a universal microplate reader (BioTek Instruments). This experiment was performed in triplicate and the results are presented as the mean ± SD.
Real-time reverse transcription polymerase chain reaction (real-time RT-PCR)
Sense and antisense primers for real-time reverse transcription polymerase chain reaction
Western blot analysis
To explore the effects of E2 on odonto/osteogenic differentiation of SCAP, SCAP in the control group and the E2 group were cultured for three and seven days, respectively, and then collected. For the evaluation of the MAPK signaling pathway, SCAP was seeded on 6-cm dishes. After 24 hours of incubation, cells were serum-starved for another 24 hours before exposure to E2 for 30 minutes, 60 minutes and 90 minutes, respectively. Cells in different groups were washed twice with cold PBS and lysed in radioimmunoprecipitation assay (RIPA) lysis buffer (Beyotime) containing 1 mM phenylmethylsulfonyl fluoride (PMSF). Cell debris was eliminated by centrifugation at 12,000 rpm for 15 minutes. The cytoplasm protein and nucleoprotein were obtained with a Keygen Kit (Keygen Biotech, Nanjing, China). Protein concentration was measured by the Bradford protein assay. A total of 30 μg protein per lane was loaded onto a 10% SDS-PAGE gel for electrophoresis and then electroblotted (Bio-Rad, Hercules, CA, USA) onto 0.22 μm polyvinylidene fluoride (PVDF) membrane (Millipore, Bedford, MA, USA) at 300 mA for one hour. Membranes were blocked with blocking solution (5% non-fat dried skimmed milk powder, 0.01 M PBS, 0.1% Tween-20 (PBST)) at room temperature for two hours, and subsequently incubated with primary antibodies (DMP1, 1:1000, Abcam; DSP, 1:1000, Santa Cruz; RUNX2, 1:1000, Abcam; OSX, 1:1000, Abcam; OCN, 1:1000, Millipore, Billerica, MA, USA; ERK1/2, 1:1000, Bioworld , St. Louis Park, MN, USA; phosphor-ERK1/2, 1:1000, Bioworld; JNK1/2/3, 1:1000, Bioworld; phosphor-JNK1/2/3, 1:1000, Bioworld; p38, 1:1000, Bioworld; phosphor-p38, 1:1000, Bioworld; Elk-1, 1:1000, Cell Signaling, Danvers, MA, USA; phosphor-Elk-1, 1:1000, Cell Signaling; Sp1, 1:1000, Cell Signaling; phosphor-Sp1, 1:1000, Cell Signaling; c-Jun, 1:1000, Cell Signaling; phosphor-c-Jun, 1:1000, Cell Signaling; c-Fos, 1:1000, Cell Signaling; phosphor-c-Fos, 1:1000, Cell Signaling; ER-α, 1:1000, Abcam; β-ACTIN, 1:1000, Bioworld; H3, 1:1000, Bioworld) overnight at 4°C. β-ACTIN and H3 were, respectively, used as the internal controls. Finally, the membranes were washed with PBST for 10 minutes × 3 followed by incubation in secondary antibodies (1:10,000, Boster, Wuhan, China) for one hour at 37°C, and visualized with ImageQuant LAS4000 system (GE Healthcare, Pittsburgh, PA, USA). The results were quantified with ImageJ software (National Institutes of Health, Bethesda, MD, USA). The experiment was repeated three times.
E2 treated and untreated SCAP were, respectively, cultured on glass coverslips. After three days culture, cells were washed twice with PBS, fixed in 4% polyoxymethylene for 30 minutes at room temperature, permeabilized with 0.5% Tween 20 for 10 minutes and then blocked with goat serum for 30 minutes at 37°C. After that, cells were incubated with primary antibodies (DSP, 1:50, Santa Cruz; RUNX2, 1:100, Abcam; OCN, 1:100, Millipore) overnight at 4°C. The fluorescence-labeled secondary antibody was added and incubated for one hour at room temperature. Nuclei were stained by 4,6-diamidino-2-phenylindole (DAPI; 1:1,000; Invitrogen) for two minutes. Immunofluorescence was visualized under a microscope.
The quantitative results were expressed as the mean ± SD. Independent samples t test, Chi-square test, one-way analysis of variance (ANOVA) and Tukey’s multiple comparison test were performed with SPSS 17.0 software. P values <0.05 were considered to be statistically significant.
Identification of SCAP
Dose-dependent effects of E2 on SCAP
Effects of E2 on morphology and proliferation of SCAP
SCAP were cultured in α-MEM containing 10-7 M E2 (E2 group) or 0.01% (v/v) ethyl alcohol as control (control group). Both the control group and the E2 group presented a spindle-like morphology and shared almost the same appearance (Figure 2C-F). FCM analysis showed no distinct difference (P >0.05) in the proliferation index (PI = G2M + S) between the control group (6.67%) and the E2 group (7.37%) (Figure 2G-I). MTT assay on 11 consecutive days also presented no significant difference (P >0.05) between the two groups (Figure 2J), and neither did the results of a colony forming assay between the control group and the E2 group (Figure 2K and L). E2 had no significant effect on the morphology and proliferation of SCAP.
Effects of E2 on odonto/osteogenic differentiation of SCAP
SCAP were cultured in routine media or MM with or without E2. At day 5, E2 exerted no influence on ALP activity of SCAP in routine media, while ALP activity was noticeably upregulated by E2 in MM (Figure 3C; P <0.01). At day 7, both E2-treated groups exhibited a significant increase in ALP activity of SCAP (Figure 3C; P <0.01). Moreover, alizarin red staining and quantitative calcium measurement demonstrated that SCAP treated with E2 produced more calcium nodules after 14 days of incubation (Figure 3D and E; P <0.05). When observed under an inverted microscope, the calcium nodules formed in routine media were fewer and smaller, whereas SCAP generated more and larger calcium nodules in MM. Moreover, the shape of the calcium nodules in the MM + E2 group was more regular than in other groups (Figure 3F-I).
Involvement of the MAPK pathway during differentiation of E2-treated SCAP
Diverse research has revealed that estrogen can exert some effects on bone and mesenchymal stem cells (MSCs). Exogenous estrogen can not only increase bone mineral density and promote bone formation, but also has beneficial effects on the proliferation and differentiation of BMMSCs[16, 22–25]. Even adipose tissue-derived stem cells (ADSCs) can possess osteogenic differentiation potential after estrogen stimulation, with greater nodule formation and mineral deposition. Estrogen has also been reported to increase ALP activity, the expression of osteocalcin and mineralized nodules in PDLSCs. Our previous study revealed that exogenous estrogen at physiological concentrations can enhance the odonto/osteogenic differentiation of DPSCs.
In the present study, a higher concentration of E2 (10-5 M) significantly inhibited the proliferation of SCAP while 10-7 and 10-9 M E2 had no effect on cell growth, indicating that there may exist a dose-dependent manner of E2 in regulating the proliferation of SCAP. To evaluate the effects of E2 on the differentiation of SCAP under similar conditions, impacts of E2 on cell proliferation should be excluded. E2 at 10-7 M did not have any negative influence on cell morphology and cell proliferation as indicated by MTT, FCM and colony forming assay, while this concentration of E2 can trigger the differentiation of SCAP. Thus, 10-7 M E2 was selected as the optimal concentration to stimulate the differentiation of SCAP in vitro.
After E2 treatment, ALP activity, mineralization capacity and odonto/osteogenic markers (ALP, DMP1/DMP1, DSPP/DSP, RUNX2/RUNX2, OSX/OSX and OCN/OCN) in SCAP were significantly upregulated. DSP protein and DSPP mRNA are tooth-specific markers that contribute to the formation of dentin and they have been reported to be expressed only in secretory odontoblasts[28–30]. DSP protein and DSPP mRNA have been identified as late-stage markers of odontoblasts, the expression of which indicates the mature differentiation of odontoblasts. DMP1 is expressed in odontoblasts and secretes matrix proteins to form dentin, which contributes to later dentinogenesis during postnatal development. Moreover, research has suggested that DSPP is a downstream effector molecule of DMP1 which is probably regulated by DMP1 during dentinogenesis[32, 33]. ALP, RUNX2 and OSX are early-stage markers of osteoblastic differentiation while OCN is related to the late-stage osteoblastic differentiation[24, 34–36]. ALP is expressed early in the developing osteoblast, during the phase of matrix deposition and is downregulated in calcifying osteoblasts. RUNX2 is a crucial factor in osteoblast and odontoblast differentiation, regulating the expression of a variety of bone-/tooth-related genes. Previous studies have revealed that Runx2-deficient mice have impaired tooth formation while RUNX2 overexpression induces new bone generation[37, 38]. OSX is a downstream gene of RUNX2, which plays an important role in osteogenic differentiation and bone formation and is expressed in functional odonto/osteoblasts[8, 39]. OCN is considered a marker for bone formation in the late stage, which has a close relationship with bone maturation. In the present study, both early-stage and late-stage odonto/osteogenic markers were upregulated, implying the long-term effects of E2 on the differentiation of SCAP.
Previous research has revealed that estrogen stimulates sequential differentiation of osteoblasts and increases calcium deposition in cultured BMSSCs in an estrogen receptor (ER)-dependent manner. As the classic steroid receptors, ERs (including ER-α and ER-β) generally mediate the biological responses to estrogen via genomic and non-genomic effects. It is suggested that the concentration of ERs is an important determinant of cellular responsiveness to estrogen[43–45]. Moreover, an increased level of ER has been detected during the osteoblastic differentiation of rat calvarial osteoblasts. In this study, E2-treated SCAP showed higher expression of ER-α and enhanced odonto/osteogenic potential. Recent studies have suggested that estrogen’s effects on various tissues may be mediated by different cell signaling pathways. E2 can regulate the bioactivity of ER-α-positive endometrial cancer cells on the basis of the MAPK signaling pathway. MAPK are an important family of protein kinases involved in transmitting signals from the cell membrane to the nucleus. There are three well-characterized subfamilies of MAPK, that is, extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinase (JNK) and p38 MAPK. MAPK signaling regulates cell proliferation, differentiation, survival and apoptosis in a variety of cells. In this study, E2 has some effects on the expression of phosphor-JNK and phosphor-p38 but did not change the level of phosphor-ERK, indicating the activation of JNK signaling and p38 MAPK signaling. In addition, the decreased level of mineralization and differentiation in E2-treated SCAP co-cultured with SP600125 or SB203580 confirmed the potential functions of JNK and p38 MAPK signaling. Therefore, it can be concluded that E2 regulates the odonto/osteogenic differentiation of SCAP via activation of the JNK and p38 MAPK pathways.
To further evaluate the MAPK signaling involved in E2-mediated differentiation of SCAP, the nuclear downstream transcription factors of MAPK were investigated by western blot analysis. The phosphorylation of all related transcription factors (phosphor-Sp1, phosphor-Elk-1, phosphor-c-Jun and phosphor-c-Fos) can be detected in a time-dependent manner, indicating the activation of these downstream factors by E2 stimulation. E2 action occurs via the classical genomic and non-genomic ways. The genomic pathway is a slow progress mediated through ERs by binding to an estrogen-responsive element (ERE) in the promotor region of different target genes, whereas the non-genomic action of E2 mediated by a membrane-associated receptor (mER) is very fast. It is suggested that liganded ERs can not only bind directly to ERE to regulate the transcription of genes, but also are tethered to DNA by interacting with other transcription factors, such as Sp1 and activating protein-1 (AP-1) to influence the gene expression, which means E2 can induce the expression of related genes through ER/Sp1 and ER/AP-1 complexes[52, 53]. In addition, E2 can trigger rapid effects including activation of a sequential series of kinases and phosphatases through membranes, such as the MAPK signaling pathway, and then induce the phosphorylation of ERs in the nuclei to regulate transcription[42, 54]. As is known, when activated by upstream factors, JNK can stimulate the phosphorylation of c-Jun, its major downstream substrate, which can interact with c-Fos to form a complex, leading to enhanced AP-1 and upregulated transcription activity. In addition, the activation of p38 MAPK also contributes to the formation of AP-1 by producing c-Jun and c-Fos. Moreover, JNK activation can induce the phosphorylation of Elk-1 and promote subsequent transcription activities. Interestingly, E2 activated JNK and p38 MAPK pathways, but had no effect on the ERK pathway in this study. However, the downstream factors of all three of these pathways were activated by E2. This indicates that these downstream transcription factors can not only be activated by their upstream kinases, such as ERK, JNK and p38 MAPK, but can also be triggered by ligand-bound ERs directly. Therefore, we speculate that E2 may play an important role during the crosstalk between the ER and MAPK signaling pathways.
In this study, E2 can promote the odonto/osteogenic differentiation of SCAP. Thus, E2 can be used to stimulate the differentiation of SCAP in the apical papillae suffering from pulp infections to recover the interrupted root development. Moreover, when cultured with PDLSCs together in vivo, they can form a biological root (bio-root) as previously reported. Recent studies also reported that E2 can enhance the proliferation and differentiation of PDLSCs. Thus, when the two kinds of cells are co-cultured with E2, they may generate a bio-root more regularly and efficiently. However, tooth growth is a complicated process that is affected by a series of factors, including patients’ conditions, cell activity, growth factors and so on. More work is required to make SCAP and E2 better applied in future clinical practice.
In conclusion, E2 enhanced the odonto/osteogenic differentiation of SCAP via activation of the MAPK signaling pathway. These findings provide a new insight into the use of E2 for tooth engineering. More work has to be performed to explore other potential mechanisms involved in the differentiation of E2-treated SCAP, which may help the application of E2 in future endodontic practice.
adipose tissue-derived stem cells
absorbable gelatin sponges
bone marrow mesenchymal stem cells
dentin matrix protein 1
dental pulp stem cells
estrogen response elements
extracellular signal-regulated kinase
fetal bovine serum
- H & E:
hematoxylin and eosin
c-Jun N-terminal kinase
mitogen-activated protein kinase
mesenchymal stem cells
periodontal ligament stem cells
reverse transcription polymerase chain reaction
runt-related transcription factor 2
stem cells while stem cells from apical papilla
alpha minimum essential medium.
This work was supported by the National Natural Science Foundation of China (No. 81371144), the Natural Science Foundation of Jiangsu Province (No. BK20131392), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, No. 2014–37).
- Huang GT: A paradigm shift in endodontic management of immature teeth: conservation of stem cells for regeneration. J Dent. 2008, 36: 379-386. 10.1016/j.jdent.2008.03.002.View ArticlePubMedGoogle Scholar
- Huang GT, Sonoyama W, Liu Y, Liu H, Wang S, Shi S: The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and BioRoot engineering. J Endod. 2008, 34: 645-651. 10.1016/j.joen.2008.03.001.PubMed CentralView ArticlePubMedGoogle Scholar
- Huang GT: Apexification: the beginning of its end. Int Endod J. 2009, 42: 855-866. 10.1111/j.1365-2591.2009.01577.x.View ArticlePubMedGoogle Scholar
- Sonoyama W, Liu Y, Yamaza T, Tuan RS, Wang S, Shi S, Huang GT: Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod. 2008, 34: 166-171. 10.1016/j.joen.2007.11.021.PubMed CentralView ArticlePubMedGoogle Scholar
- Sonoyama W, Liu Y, Fang D, Yamaza T, Seo BM, Zhang C, Liu H, Gronthos S, Wang CY, Wang S, Shi S: Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS One. 2006, 1: e79-10.1371/journal.pone.0000079.PubMed CentralView ArticlePubMedGoogle Scholar
- Abe S, Yamaguchi S, Watanabe A, Hamada K, Amagasa T: Hard tissue regeneration capacity of apical pulp derived cells (APDCs) from human tooth with immature apex. Biochem Biophys Res Commun. 2008, 371: 90-93. 10.1016/j.bbrc.2008.04.016.View ArticlePubMedGoogle Scholar
- Dadu SS: Tooth regeneration: current status. Indian J Dent Res. 2009, 20: 506-550. 10.4103/0970-9290.59444.View ArticlePubMedGoogle Scholar
- Wang Y, Zheng Y, Wang Z, Li J, Zhang G, Yu J: 10(–7) m17β-oestradiol enhances odonto/osteogenic potency of human dental pulp stem cells by activation of the NF-κB pathway. Cell Prolif. 2013, 46: 677-684. 10.1111/cpr.12071.PubMed CentralView ArticlePubMedGoogle Scholar
- Bakopoulou A, Leyhausen G, Volk J, Koidis P, Geurtsen W: Comparative characterization of STRO-1neg/CD146pos and STRO-1pos/CD146pos apical papilla stem cells enriched with flow cytometry. Arch Oral Biol. 2013, 58: 1556-1568. 10.1016/j.archoralbio.2013.06.018.View ArticlePubMedGoogle Scholar
- Ruparel NB, Teixeira FB, Ferraz CC, Diogenes A: Direct effect of intracanal medicaments on survival of stem cells of the apical papilla. J Endod. 2012, 38: 1372-1375. 10.1016/j.joen.2012.06.018.View ArticlePubMedGoogle Scholar
- Jiang Q, Du J, Yin X, Shan Z, Ma Y, Ma P, Fan Z: Shh signaling, negatively regulated by BMP signaling, inhibits the osteo/dentinogenic differentiation potentials of mesenchymal stem cells from apical papilla. Mol Cell Biochem. 2013, 383: 85-93. 10.1007/s11010-013-1757-9.View ArticlePubMedGoogle Scholar
- Wang Y, Yan M, Yu Y, Wu J, Yu J, Fan Z: Estrogen deficiency inhibits the odonto/osteogenic differentiation of dental pulp stem cells via activation of the NF-κB pathway. Cell Tissue Res. 2013, 352: 551-559. 10.1007/s00441-013-1604-z.View ArticlePubMedGoogle Scholar
- Xue P, Wang Y, Yang J, Li Y: Effects of growth hormone replacement therapy on bone mineral density in growth hormone deficient adults: a meta-analysis. Int J Endocrinol. 2013, 2013: 1-13.View ArticleGoogle Scholar
- Bin Zhang YL, Zhou Q, Ding Y: Estrogen deficiency leads to impaired osteogenic differentiation of periodontal ligament stem cells in rats. Tohoku J Exp Med. 2011, 223: 177-186. 10.1620/tjem.223.177.View ArticlePubMedGoogle Scholar
- Mamalis A, Markopoulou C, Lagou A, Vrotsos I: Oestrogen regulates proliferation, osteoblastic differentiation, collagen synthesis and periostin gene expression in human periodontal ligament cells through oestrogen receptor beta. Arch Oral Biol. 2011, 56: 446-455. 10.1016/j.archoralbio.2010.11.001.View ArticlePubMedGoogle Scholar
- Zhang M, Chen FM, Wang AH, Chen YJ, Lv X, Wu S, Zhao RN: Estrogen and its receptor enhance mechanobiological effects in compressed bone mesenchymal stem cells. Cells Tissues Organs. 2012, 195: 400-413. 10.1159/000328003.View ArticlePubMedGoogle Scholar
- Zhao JW, Gao ZL, Mei H, Li YL, Wang Y: Differentiation of human mesenchymal stem cells: the potential mechanism for estrogen-induced preferential osteoblast versus adipocyte differentiation. Am J Med Sci. 2011, 341: 460-468. 10.1097/MAJ.0b013e31820865d5.View ArticlePubMedGoogle Scholar
- Yu J, Wang Y, Deng Z, Tang L, Li Y, Shi J, Jin Y: Odontogenic capability: bone marrow stromal stem cells versus dental pulp stem cells. Biol Cell. 2007, 99: 465-474. 10.1042/BC20070013.View ArticlePubMedGoogle Scholar
- Lei G, Yan M, Wang Z, Yu Y, Tang C, Yu J, Zhang G: Dentinogenic capacity: immature root papilla stem cells versus mature root pulp stem cells. Biol Cell. 2011, 103: 185-196. 10.1042/BC20100134.View ArticlePubMedGoogle Scholar
- Wang S, Mu J, Fan Z, Yu Y, Yan M, Lei G, Tang C, Wang Z, Zheng Y, Yu J, Zhang G: Insulin-like growth factor 1 can promote the osteogenic differentiation and osteogenesis of stem cells from apical papilla. Stem Cell Res. 2012, 8: 346-356. 10.1016/j.scr.2011.12.005.View ArticlePubMedGoogle Scholar
- Yu J, He H, Tang C, Zhang G, Li Y, Wang R, Shi J, Jin Y: Differentiation potential of STRO-1+ dental pulp stem cells changes during cell passaging. BMC Cell Biol. 2010, 11: 32-10.1186/1471-2121-11-32.PubMed CentralView ArticlePubMedGoogle Scholar
- Galea GL, Price JS, Lanyon LE: Estrogen receptors’ roles in the control of mechanically adaptive bone (re)modeling. Bonekey Rep. 2013, 2: 413-PubMed CentralView ArticlePubMedGoogle Scholar
- Ozono S, Fujita T, Matsuo M, Todoki K, Ohtomo T, Negishi H, Kawase T: Co-treatment with basic fibroblast growth factor and 17beta-estradiol in the presence of dexamethasone accelerates bone formation by rat bone marrow stromal cell culture. Nihon Hotetsu Shika Gakkai Zasshi. 2008, 52: 366-374. 10.2186/jjps.52.366.View ArticlePubMedGoogle Scholar
- Gopalakrishnan V, Vignesh RC, Arunakaran J, Aruldhas MM, Srinivasan N: Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol. 2006, 84: 93-101. 10.1139/o05-163.View ArticlePubMedGoogle Scholar
- Hong L, Colpan A, Peptan IA: Modulations of 17-β estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells. Tissue Eng. 2006, 12: 2747-2753. 10.1089/ten.2006.12.2747.View ArticlePubMedGoogle Scholar
- Taskiran D, Evren V: Stimulatory effect of 17β-estradiol on osteogenic differentiation potential of rat adipose tissue-derived stem cells. Gen Physiol Biophys. 2011, 30: 167-174. 10.4149/gpb_2011_02_167.View ArticlePubMedGoogle Scholar
- Liang L, Yu JF, Wang Y, Wang G, Ding Y: Effect of estrogen receptor beta on the osteoblastic differentiation function of human periodontal ligament cells. Arch Oral Biol. 2008, 53: 553-557. 10.1016/j.archoralbio.2007.12.011.View ArticlePubMedGoogle Scholar
- Iejima D, Sumita Y, Kagami H, Ando Y, Ueda M: Odontoblast marker gene expression is enhanced by a CC-chemokine family protein MIP-3α in human mesenchymal stem cells. Arch Oral Biol. 2007, 52: 924-931. 10.1016/j.archoralbio.2007.04.004.View ArticlePubMedGoogle Scholar
- Chen S, Gluhak-Heinrich J, Wang YH, Wu YM, Chuang HH, Chen L, Yuan GH, Dong J, Gay I, MacDougall M: Runx2, osx, and dspp in tooth development. J Dent Res. 2009, 88: 904-909. 10.1177/0022034509342873.PubMed CentralView ArticlePubMedGoogle Scholar
- Yamazaki H, Kunisada T, Miyamoto A, Tagaya H, Hayashi SI: Tooth-specific expression conferred by the regulatory sequences of rat dentin sialoprotein gene in transgenic mice. Biochem Biophys Res Commun. 1999, 260: 433-440. 10.1006/bbrc.1999.0875.View ArticlePubMedGoogle Scholar
- Yamakoshi Y: Dentinogenesis and Dentin Sialophosphoprotein (DSPP). J Oral Biosci. 2009, 51: 134-10.1016/S1349-0079(09)80021-2.PubMed CentralView ArticlePubMedGoogle Scholar
- Ye L, MacDougall M, Zhang S, Xie Y, Zhang J, Li Z, Lu Y, Mishina Y, Feng JQ: Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development. J Biol Chem. 2004, 279: 19141-19148. 10.1074/jbc.M400490200.View ArticlePubMedGoogle Scholar
- Gibson MP, Zhu Q, Wang S, Liu Q, Liu Y, Wang X, Yuan B, Ruest LB, Feng JQ, D'Souza RN, Qin C, Lu Y: The rescue of dentin matrix protein 1 (DMP1)-deficient tooth defects by the transgenic expression of dentin sialophosphoprotein (DSPP) indicates that DSPP is a downstream effector molecule of DMP1 in dentinogenesis. J Biol Chem. 2013, 288: 7204-7214. 10.1074/jbc.M112.445775.PubMed CentralView ArticlePubMedGoogle Scholar
- Komori T: Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol. 2010, 658: 43-49.View ArticlePubMedGoogle Scholar
- Ni P, Fu S, Fan M, Guo G, Shi S, Peng J, Luo F, Qian Z: Preparation of poly(ethylene glycol)/polylactide hybrid fibrous scaffolds for bone tissue engineering. Int J Nanomedicine. 2011, 6: 3065-3075.PubMed CentralPubMedGoogle Scholar
- Wade-Gueye NM, Boudiffa M, Vanden-Bossche A, Laroche N, Aubin JE, Vico L, Lafage-Proust MH, Malaval L: Absence of bone sialoprotein (BSP) impairs primary bone formation and resorption: the marrow ablation model under PTH challenge. Bone. 2012, 50: 1064-1073. 10.1016/j.bone.2012.02.014.View ArticlePubMedGoogle Scholar
- D'Souza RN, Aberg T, Gaikwad J, Cavender A, Owen M, Karsenty G, Thesleff I: Cbfa1 is required for epithelial-mesenchymal interactions regulating tooth development in mice. Development. 1999, 126: 2911-2920.PubMedGoogle Scholar
- Takahashi T: Overexpression of Runx2 and MKP-1 stimulates transdifferentiation of 3 T3-L1 preadipocytes into bone-forming osteoblasts in vitro. Calcif Tissue Int. 2011, 88: 336-347. 10.1007/s00223-011-9461-9.View ArticlePubMedGoogle Scholar
- Baek WY, Lee MA, Jung JW, Kim SY, Akiyama H, de Crombrugghe B, Kim JE: Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J Bone Miner Res. 2009, 24: 1055-1065. 10.1359/jbmr.081248.PubMed CentralView ArticlePubMedGoogle Scholar
- Neugebauer BM, Moore MA, Broess M, Gerstenfeld LC, Hauschka PV: Characterization of structural sequences in the chicken osteocalcin gene: expression of osteocalcin by maturing osteoblasts and by hypertrophic chondrocytes in vitro. J Bone Miner Res. 1995, 10: 157-163.View ArticlePubMedGoogle Scholar
- Qu Q, Perala-Heape M, Kapanen A, Dahllund J, Salo J, Vaananen HK, Harkonen P: Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone. 1998, 22: 201-209. 10.1016/S8756-3282(97)00276-7.View ArticlePubMedGoogle Scholar
- Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA: Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007, 87: 905-931. 10.1152/physrev.00026.2006.View ArticlePubMedGoogle Scholar
- Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996, 93: 5925-5930. 10.1073/pnas.93.12.5925.PubMed CentralView ArticlePubMedGoogle Scholar
- Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol. 1997, 11: 353-365.PubMedGoogle Scholar
- Santagati S, Gianazza E, Agrati P, Vegeto E, Patrone C, Pollio G, Maggi A: Oligonucleotide squelching reveals the mechanism of estrogen receptor autologous down-regulation. Mol Endocrinol. 1997, 11: 938-949. 10.1210/mend.11.7.9936.View ArticlePubMedGoogle Scholar
- Bodine PV, Henderson RA, Green J, Aronow M, Owen T, Stein GS, Lian JB, Komm BS: Estrogen receptor-alpha is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology. 1998, 139: 2048-2057.PubMedGoogle Scholar
- Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC: Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest. 2003, 111: 1651-1664. 10.1172/JCI200317261.PubMed CentralView ArticlePubMedGoogle Scholar
- Migliaccio A, Zhou C, Steplowski TA, Dickens HK, Malloy KM, Gehrig PA, Boggess JF, Bae-Jump VL: Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells. PLoS One. 2013, 8: e55730-10.1371/journal.pone.0055730.View ArticleGoogle Scholar
- Derwahl M, Nicula D: Estrogen and its role in thyroid cancer. Endocr Relat Cancer. 2014, 21: T273-T283. 10.1530/ERC-14-0053.View ArticlePubMedGoogle Scholar
- Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA: Mechanisms of estrogen action. Physiol Rev. 2001, 81: 1535-1565.PubMedGoogle Scholar
- Moriarty K, Kim KH, Bender JR: Minireview: estrogen receptor-mediated rapid signaling. Endocrinology. 2006, 147: 5557-5563. 10.1210/en.2006-0729.View ArticlePubMedGoogle Scholar
- Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson JA, Safe S: Ligand-, cell-, and estrogen receptor subtype (alpha /beta )-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem. 2000, 275: 5379-5387. 10.1074/jbc.275.8.5379.View ArticlePubMedGoogle Scholar
- Babu RL, Naveen Kumar M, Patil RH, Devaraju KS, Ramesh GT, Sharma SC: Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation. Mol Cell Biochem. 2013, 380: 143-151. 10.1007/s11010-013-1667-x.View ArticlePubMedGoogle Scholar
- Xiao HH, Gao QG, Zhang Y, Wong KC, Dai Y, Yao XS, Wong MS: Vanillic acid exerts oestrogen-like activities in osteoblast-like UMR 106 cells through MAP kinase (MEK/ERK)-mediated ER signaling pathway. J Steroid Biochem Mol Biol. 2014, 144 Pt B: 382-391.View ArticlePubMedGoogle Scholar
- Tang YQ, Jaganath I, Manikam R, Sekaran SD: Phyllanthus suppresses prostate cancer cell, PC-3, proliferation and induces apoptosis through multiple signalling pathways (MAPKs, PI3K/Akt, NFkappaB, and hypoxia). Evid Based Compl Alternat Med. 2013, 2013: 609581-Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.